Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Transdermal and Topical Drug Delivery' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Transdermal Drug Delivery Technologies, Markets and Companies |
Jan 2012 | £1,945 | 100% |
| Drug Delivery Technologies Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies |
Sep 2008 | £2,215 | 94% |
| The Global Drug Delivery Market Research Trends and Market Outlook |
May 2006 | £1,265 | 93% |
| Freedonia Focus on Transdermal & Implantable Drug Delivery Systems | Dec 2008 | £315 | 92% |
| Advanced Drug Delivery Systems New Developments, New Technologies |
Aug 2009 | £3,065 | 92% |
| Drug Delivery Series I-IV | Apr 2007 | £4,520 | 90% |
| Neurological Disorders - Physician Perspective 2008 U.S. Drug Delivery |
Nov 2010 | £6,325 | 89% |
| Pain Therapeutics Technologies, Markets and Companies |
Jan 2012 | £2,590 | 88% |
| Advanced Drug Delivery Technologies Enabling Drug Reformulations and Administration Routes |
Jan 2011 | £2,020 | 87% |
| Anesthesia Drugs Worldwide Markets |
Jul 2007 | £2,145 | 86% |
| 2008 U.S. Inflammatory Diseases Drug Delivery Physician Perspective |
Nov 2010 | £6,325 | 85% |
| Pediatric Drug Delivery Technology and Product Opportunities, 2nd Edition |
Oct 2010 | £1,010 | 84% |
| Chinese Markets for Drug Delivery System | Nov 2010 | £2,530 | 83% |
| Drug Delivery Systems US Market Outlook, Advances for Pharma, Biotech & Medical Devices |
Sep 2006 | £1,450 | 82% |
| Nanobiotechnology (2 parts) Applications, Markets and Companies |
Jan 2012 | £3,240 | 79% |
| 2008 U.S. Diabetes Drug Delivery - Patient Perspective | May 2010 | £3,795 | 79% |
| Top 10 Drug Delivery Technologies Market | Feb 2011 | £2,940 | 78% |
| Antiviral Therapeutics Technologies, Markets and Companies |
Jan 2012 | £2,265 | 77% |
| The World Anesthesia Drug Market | Apr 2010 | £2,525 | 76% |
| Phosphagenics Limited – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 76% |
| Emerging Drug Delivery Technologies & Strategies: Players, Pipelines & Partnerships Assessing the Lipid-based, Polymer-based and Biovector delivery sectors |
Sep 2011 | £1,295 | 76% |
| Cardiovascular Drug Delivery Technologies, Markets and Companies |
Jan 2012 | £1,815 | 74% |
| Competitor Analysis: Therapeutic Proteins Biosimilars, Biobetters & Biosuperiors |
Feb 2011 | £1,320 | 69% |
| Excipients in Pharmaceuticals | Aug 2011 | £3,065 | 66% |
| Gene Therapy (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 65% |
| The Global Market for Pain Management Drugs and Devices | Aug 2009 | £3,065 | 65% |
| Dermatological Therapeutics Global Markets |
Jan 2009 | £3,065 | 64% |
| Nanotechnology: Players, products & prospects to 2018 (Volume II) | Jan 2012 | £595 | 60% |
| Drug Delivery Technologies: Players, products & prospects to 2018 | Jun 2009 | £1,795 | 49% |
- Results 1 - 29 of 29
-
-
- 1
-
-
